DENTSPLY SIRONA Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed on November 25, 2025, by DENTSPLY SIRONA Inc. The filing addresses a significant corporate governance event under Item 8.01 (Other Events) regarding executive leadership changes.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Michael Pomeroy as Interim Chief Financial Officer (CFO), effective November 25, 2025. Concurrently, Daniel T. Scavilla, the President and Chief Executive Officer, will continue to serve as the Company's principal financial officer until a permanent CFO is identified.
Management Commentary and Background
Mr. Pomeroy brings extensive finance leadership experience across Industrial/Manufacturing, Healthcare, Consumer Retail, and Distribution sectors. His recent roles include:
- Interim CFO of Highridge Medical (February 2025 – September 2025).
- Executive Vice President and CFO of Icahn Automotive Group (2022–2024).
- Executive Vice President and CFO of Hollander-Keeco (2021–2022).
- Vice President and CFO of RGIS (2017–2021).
His career began at GE in 1981, where he remained until 2000.
Key Facts for Investor Verification
- Michael Pomeroy is serving in a temporary capacity as Interim CFO.
- Daniel T. Scavilla retains the title of principal financial officer during the interim period.
- The Company has not yet identified a permanent Chief Financial Officer.
- No financial results or guidance were disclosed in this specific filing.